NCT06282315: Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and Effectiveness |
|
|
| Not yet recruiting | 4 | 20000 | RoW | Pre-screening Phase, Screenig Phase, Randomization, Baseline Effectiveness Cohort, Day 0 Trial Intervention, Mass Drug Administration (MDA), Active Surveillance (study visit Day 1, Day 2 and Day 7), Passive Surveillance, Post-Treatment Effectiveness Evaluation | Insud Pharma, Ghana Health Services, Kenya Medical Research Institute, Bridges to Development, Sanger Institute, Barcelona Institute for Global Health, European Union, Swiss Confederation, Mundo Sano | Soil-Transmitted Helminths | 02/26 | 06/26 | | |
